Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal.Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used to…
Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy
![](https://globallegalchronicle.com/wp-content/uploads/2023/06/cyclerion-therapeutics-sale-of-medicine-to-treat-mitochondrial-encephalopathy_648c1a5562663.jpeg)